Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTCX:US

24.37 USD 0.28 1.14%

As of 09:29:30 ET on 02/27/2015.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTCX)

Year To Date: +11.13% 3-Month: +13.17% 3-Year: +42.33% 52-Week Range: 15.42 - 24.65
1-Month: +4.55% 1-Year: +23.33% 5-Year: +32.50% Beta vs MXWO: 1.02

Mutual Fund Chart for FBTCX

No chart data available.
  • FBTCX:US 24.37
  • 1M
  • 1Y
Interactive FBTCX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTCX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTCX

NAV (on 2015-02-27) 24.37
Assets (M) (on 2015-01-30) 2,547.32
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTCX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-12) 0.42
Dividend Yield (ttm) 2.48

Fees & Expenses for FBTCX

Front Load 0.00
Back Load 1.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.83

Top Fund Holdings for FBTCX

Filing Date: 12/31/2014
Name Position Value % of Total
Gilead Sciences Inc 1,891,207 178,265,172 8.001%
Celgene Corp 1,540,677 172,340,129 7.736%
Biogen Idec Inc 453,075 153,796,309 6.903%
Alexion Pharmaceuticals Inc 639,024 118,238,611 5.307%
Vertex Pharmaceuticals Inc 916,326 108,859,529 4.886%
Regeneron Pharmaceuticals Inc 248,461 101,931,125 4.575%
Amgen Inc 387,830 61,777,441 2.773%
BioMarin Pharmaceutical Inc 611,761 55,303,194 2.482%
Receptos Inc 450,142 55,146,896 2.475%
Medivation Inc 431,077 42,939,580 1.927%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil